Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large b-cell lymphoma: A review of the literature

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Tirado, Carlos A ^a   Chen, Weina ^b   García, Rolando ^c   Kohlman, Kelly A ^d   Rao, Nagesh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Array CGH; DLBCL; Genomic profiles

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BURKITT LYMPHOMA; CHROMOSOME; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; KARYOTYPE; LARGE CELL LYMPHOMA; LYMPHOMATOID GRANULOMATOSIS; MICROARRAY ANALYSIS; PLASMABLASTIC LYMPHOMA; PLEURA EMPYEMA; PRIMARY EFFUSION LYMPHOMA; REVIEW;

COMPARATIVE GENOMIC HYBRIDIZATION; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICROARRAY ANALYSIS;

EID: 84865997754     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-54     Document Type: Review

References (78)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008
2. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Lenz G, et al. Proc Natl Acad Sci U S A 2008 105 36 13520 13525 10.1073/pnas.0804295105 18765795
3. Is there a role for cetuximab in non small cell lung cancer? Morgensztern D, Govindan R, Clin Cancer Res 2007 13 15 Pt 2 4602 4605
4. Steven S, Nancy Lee H, Elaine J, Harald S, Jurgen T, James V, A. Pileri S, C E, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008
5. Polymorphisms in the 3'-untranslated region of the CDH1 gene are a risk factor for primary gastric diffuse large B-cell lymphoma. Jacobs G, et al. Haematologica 2011 96 7 987 995 10.3324/haematol.2010.033126 21459793
6. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. Thunberg U, et al. Leuk Lymphoma 2010 51 8 1563 1566 10.3109/10428194.2010.492486 20578820
7. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma. Worrillow L, et al. Cancer Epidemiol 2009 33 3-4 257 260 10.1016/j.canep.2009.08.002 19736055
8. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Wang SS, et al. Leukemia 2009 23 3 596 602 10.1038/leu.2008.240 18830263
9. Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. Kumar V, et al. J Hum Genet 2011 56 6 436 439 10.1038/jhg.2011.35 21471979
10. Diffuse large B-cell lymphoma-more than a diffuse collection of large B cells: an entity in search of a meaningful classification. Gurbuxani S, Anastasi J, Hyjek E, Arch Pathol Lab Med 2009 133 7 1121 1134 19642739
11. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Alizadeh AA, et al. Nature 2000 403 6769 503 511 10.1038/35000501 10676951 (Pubitemid 30082188)
12. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Wright G, et al. Proc Natl Acad Sci U S A 2003 100 17 9991 9996 10.1073/pnas.1732008100 12900505 (Pubitemid 37087056)
13. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. Rosenwald A, et al. N Engl J Med 2002 346 25 1937 1947 10.1056/NEJMoa012914 12075054 (Pubitemid 34651353)
14. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Shipp MA, et al. Nat Med 2002 8 1 68 74 10.1038/nm0102-68 11786909 (Pubitemid 34101731)
15. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Kramer MH, et al. Blood 1998 92 9 3152 3162 9787151 (Pubitemid 28492322)
16. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. Davis RE, et al. J Exp Med 2001 194 12 1861 1874 10.1084/jem.194.12.1861 11748286 (Pubitemid 34028664)
17. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Lam LT, et al. Clin Cancer Res 2005 11 1 28 40 15671525 (Pubitemid 40075775)
18. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. Rosenwald A, et al. J Exp Med 2003 198 6 851 862 10.1084/jem.20031074 12975453 (Pubitemid 37152922)
19. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Savage KJ, et al. Blood 2003 102 12 3871 3879 10.1182/blood-2003-06-1841 12933571 (Pubitemid 37486965)
20. Primary mediastinal large B-cell lymphoma. Savage KJ, Oncologist 2006 11 5 488 495 10.1634/theoncologist.11-5-488 16720849 (Pubitemid 43788275)
21. Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Bentz M, et al. Genes Chromosomes Cancer 2001 30 4 393 401 10.1002/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I 11241792 (Pubitemid 32216330)
22. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Wessendorf S, et al. Lab Invest 2002 82 1 47 60 10.1038/labinvest.3780394 11796825 (Pubitemid 34072645)
23. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Tagawa H, et al. Blood 2005 106 5 1770 1777 10.1182/blood-2005-02-0542 15886317 (Pubitemid 41208593)
24. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Bea S, et al. Blood 2005 106 9 3183 3190 10.1182/blood-2005-04-1399 16046532 (Pubitemid 41565917)
25. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Chen W, et al. Blood 2006 107 6 2477 2485 10.1182/blood-2005-07-2950 16317097 (Pubitemid 43345571)
26. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas. Rinaldi A, et al. Br J Haematol 2006 134 1 27 36 10.1111/j.1365-2141.2006.06114.x 16803564 (Pubitemid 43830024)
27. High resolution array comparative genomic hybridization identifies copy number alterations in diffuse large B-cell lymphoma that predict response to immuno-chemotherapy. Kreisel F, et al. Cancer Genet 2011 204 3 129 137 10.1016/j.cancergen.2010.12.010 21504712
28. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. Perez-Rosado A, et al. J Pathol 2008 214 4 498 507 18189332 (Pubitemid 351340570)
29. Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma. Muris JJ, et al. Hematol Oncol 2006 24 3 97 104 10.1002/hon.774 16715473 (Pubitemid 44483901)
30. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Lam LT, et al. Blood 2008 111 7 3701 3713 10.1182/blood-2007-09-111948 18160665
31. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Niu H, Ye BH, Dalla-Favera R, Genes Dev 1998 12 13 1953 1961 10.1101/gad.12.13.1953 9649500 (Pubitemid 28323870)
32. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Steinbach D, et al. Clin Cancer Res 2006 12 14 Pt 1 4357 4363 16857811
33. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Pasqualucci L, et al. Nature 2001 412 6844 341 346 10.1038/35085588 11460166 (Pubitemid 32691848)
34. Lymphoid malignancies: the dark side of B-cell differentiation. Shaffer AL, Rosenwald A, Staudt LM, Nat Rev Immunol 2002 2 12 920 932 10.1038/nri953 12461565 (Pubitemid 37323213)
35. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Wlodarska I, et al. Leukemia 2005 19 8 1299 1305 10.1038/sj.leu.2403813 15944719 (Pubitemid 41136318)
36. Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein. Motoyama M, et al. J Biol Chem 2005 280 9 7444 7451 15618216 (Pubitemid 40349635)
37. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. Lenz G, et al. J Exp Med 2007 204 3 633 643 10.1084/jem.20062041 17353367 (Pubitemid 46457085)
38. c-Myc-regulated microRNAs modulate E2F1 expression. O'Donnell KA, et al. Nature 2005 435 7043 839 843 10.1038/nature03677 15944709 (Pubitemid 40839736)
39. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Palanisamy N, et al. Genes Chromosomes Cancer 2002 33 2 114 122 10.1002/gcc.10016 11793437 (Pubitemid 34052492)
40. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Green MR, et al. Blood 2010 116 17 77 3268
41. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Joos S, et al. Blood 1996 87 4 1571 1578 8608249 (Pubitemid 26056923)
42. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. Barth TF, et al. Blood 2003 101 9 3681 3686 10.1182/blood-2002-08-2577 12511414 (Pubitemid 36857959)
43. Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Wessendorf S, et al. Leukemia 2007 21 12 2463 2469 10.1038/sj.leu.2404919 17728785 (Pubitemid 350148889)
44. Diffuse aggressive B-cell lymphomas. Said J, Adv Anat Pathol 2009 16 4 216 235 10.1097/PAP.0b013e3181a9d5d2 19546610
45. A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines. Feys T, et al. Haematologica 2007 92 7 913 920 10.3324/haematol.11073 17606441 (Pubitemid 350144238)
46. Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone. Heyning FH, et al. J Clin Pathol 2010 63 12 1095 1100 10.1136/jcp.2010.078915 20962053
47. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. Booman M, et al. J Pathol 2008 216 2 209 217 10.1002/path.2399 18729069
48. Primary lymphoma of the central nervous system: just DLBCL or not? Montesinos-Rongen M, Siebert R, Deckert M, Blood 2009 113 1 7 10 10.1182/blood-2008-04-149005 18802010
49. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Camilleri-Broet S, et al. Blood 2006 107 1 190 196 10.1182/blood-2005-03-1024 16150948 (Pubitemid 43053543)
50. Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomas. Belaud-Rotureau MA, et al. Virchows Arch 2008 452 6 607 620 10.1007/s00428-008-0593-x 18311490
51. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. Dijkman R, et al. J Clin Oncol 2006 24 2 296 305 16330669 (Pubitemid 46622058)
52. Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. Franke S, et al. Am J Pathol 2002 161 5 1861 1867 10.1016/S0002-9440(10)64462-8 12414532 (Pubitemid 35265543)
53. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Monti S, et al. Blood 2005 105 5 1851 1861 10.1182/blood-2004-07-2947 15550490 (Pubitemid 40731764)
54. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Matolcsy A, Chadburn A, Knowles DM, Am J Pathol 1995 147 1 207 216 7541611
55. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes. Harada S, et al. Leukemia 1999 13 9 1441 1447 10.1038/sj.leu.2401487 10482997 (Pubitemid 29429773)
56. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Yamaguchi M, et al. Blood 2002 99 3 815 821 10.1182/blood.V99.3. 815 11806981 (Pubitemid 34525540)
57. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Tagawa H, et al. Cancer Res 2004 64 17 5948 5955 10.1158/0008-5472.CAN-03-4056 15342373 (Pubitemid 39129390)
58. DNA sequences of the immunoglobulin heavy chain variable region gene in pyothorax-associated lymphoma. Miwa H, et al. Oncology 2002 62 3 241 250 10.1159/000059572 12065872 (Pubitemid 34639058)
59. Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Hongyo T, et al. Cancer Res 1998 58 6 1105 1107 9515788 (Pubitemid 28183191)
60. Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma. Yamato H, et al. Histopathology 2001 39 2 163 171 10.1046/j.1365-2559.2001.01197.x 11493333 (Pubitemid 34225043)
61. Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation. Nishiu M, et al. Cancer Sci 2004 95 10 828 834 10.1111/j.1349-7006.2004.tb02189.x 15504251 (Pubitemid 39545590)
62. Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection. Takakuwa T, et al. Cancer Sci 2003 94 10 858 863 10.1111/j.1349-7006.2003.tb01367.x 14556658 (Pubitemid 37406967)
63. Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma. Chang CC, et al. J Hematol Oncol 2009 2 47 10.1186/1756-8722-2-47 19909553
64. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Colomo L, et al. Am J Surg Pathol 2004 28 6 736 747 10.1097/01.pas.0000126781.87158.e3 15166665 (Pubitemid 38685887)
65. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. Du MQ, Bacon CM, Isaacson PG, J Clin Pathol 2007 60 12 1350 1357 18042691 (Pubitemid 350247250)
66. Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Cesarman E, Mesri EA, Curr Top Microbiol Immunol 2007 312 263 287 10.1007/978-3-540-34344-8-10 17089801 (Pubitemid 47400340)
67. Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. Luan SL, et al. J Pathol 2010 222 2 166 179 10.1002/path.2752 20690162
68. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Ohshima K, et al. Leuk Lymphoma 2002 43 3 595 601 10.1080/10428190290012100 12002764 (Pubitemid 34232928)
69. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. Hummel M, et al. N Engl J Med 2006 354 23 2419 2430 10.1056/NEJMoa055351 16760442 (Pubitemid 43855045)
70. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. McClure RF, et al. Am J Surg Pathol 2005 29 12 1652 1660 10.1097/01.pas.0000180442.87022.08 16327438
71. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ferreri AJ, et al. Ann Oncol 2004 15 8 1215 1221 10.1093/annonc/mdh274 15277261 (Pubitemid 39199308)
72. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Reichard KK, McKenna RW, Kroft SH, Mod Pathol 2007 20 3 310 319 10.1038/modpathol.3800742 17277765 (Pubitemid 46348332)
73. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review. Shimoyama Y, et al. J Clin Exp Hematop 2006 46 1 1 4 10.3960/jslrt.46.1 17058802
74. Senile EBV+B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Oyama T, et al. Am J Surg Pathol 2003 27 1 16 26 10.1097/00000478-200301000-00003 12502924 (Pubitemid 36014895)
75. Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation. Ohno H, et al. Int J Hematol 2009 89 5 8 704
76. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Du MQ, et al. Blood 2001 97 7 6 2130
77. Chromosomal abnormalities in lymphogranulomatosis X (LgrX)/ angioimmunoblastic lymphadenopathy (AILD). Godde-Salz E, Feller AC, Lennert K, Leuk Res 1987 11 2) 90 181
78. Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma. Geng H, et al. BMC Med Genomics 2011 4 32 10.1186/1755-8794-4-32 21486456